[1] PENG XH,TAN JW. Advances in diagnosis and treatment of cytomegalovirus infection after liver transplantation[J]. J Clin Hepatol,2006,22(5):396-398.(in Chinese)彭小华,谈景旺.肝移植术后巨细胞病毒感染的诊治进展[J].临床肝胆病杂志,2006,22(5):396-398.
|
[2] WU LW,HE XS,ZHU XF,et al. Diagnosis and prevention of cytomegalovirus infection after liver transplantation:A report of150 cases[J]. New Chin Med,2005,36(4):208-209.(in Chinese)巫林伟,何晓顺,朱晓峰,等.肝移植术后巨细胞病毒感染的诊断与防治———附150例报告[J].新医学,2005,36(4):208-209.
|
[3] GARDINER BJ,CHOW JK,PRICE LL,et al. Role of secondary prophylaxia with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipient[J]. Clin Infect Dis,2017,65(12):2000-2007.
|
[4] HUANG YF,LIU DP,CHEN H,et al. The epidemiological and clinical research of mid-long-term cytomegalovirus infection after liver transplantation[J/CD]. Prac J Organ Transplant(Electronic Version),2018,6(3):187-191.(in Chinese)黄云帆,刘大平,陈虹,等.肝移植术后中远期巨细胞病毒的感染情况及诊治[J/CD].实用器官移植电子杂志,2018,6(3):187-191.
|
[5] MARCELIN JR,BEAM E,RAZONABLE RR. Cytomegalovirus infection in liver transplant recipients:Updates on clinical management[J]. World J Gastroenterol,2014,20(31):10658-10667.
|
[6] KUMAR D,MIAN M,SINGER L,et al. An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation[J]. Am J Transplant,2017,17(9):2468-2473.
|
[7] JANANI MK,MALATHI J,RELA M,et al. Genotypic detection of Epstein-Barr virus in pediatric transplant recipients from India[J]. Indian Pediatrics,2015,52(11):946-950.
|
[8] NAKAZAWA A,NAKANO N,FUKUDA A,et al. Use of serial assessment of disease severity and liver biopsy for indication for liver transplantation in pediatric Epstein-Barr virus-induced fulminant hepatic failure[J]. Liver Transpl,2015,21(3):362-368.
|
[9] WANG TC,ZHU ZJ,SUN LY,et al. Risk factor analysis of EB virus infection after liver transplantation in children with biliary atresia[J]. Tianjin Med J,2016,44(7):824-828.(in Chinese)王天成,朱志军,孙丽莹,等.胆道闭锁患儿肝移植术后EB病毒感染的危险因素分析[J].天津医药,2016,44(7):824-828.
|
[10] CHEN F,ZHU LQ,LIU Y,et al. Safety evaluation of acyclovir in the treatment of liver-transplanted children with EB-viremia[J]. China Pharm,2016,27(3):313-315.(in Chinese)陈凡,朱立勤,刘洋,等.阿昔洛韦治疗儿童肝移植受者EB病毒血症的安全性评价[J].中国药房,2016,27(3):313-315.
|
[11] JIANG M,LUO CB,ZHAN H,et al. Clinical characteristic analysis on anemia associated with human parvovirus B19 infection in liver transplant recipients[J]. Chin J Clinl Med,2018,25(3):405-408.(in Chinese)蒋密,罗楚彬,战昊,等.肝移植患者人类微小病毒B19感染与相关贫血的临床特点分析[J].中国临床医学,2018,25(3):405-408.
|
[12] MA Q,XU H,SHEN Q,et al. Two cases of refractory anemia caused by parvovirus B19 infection after renal transplantation in children[J/CD]. Chin J Clinicians:Electronic Edition,2018,12(12):704-706.(in Chinese)马强,徐虹,沈茜,等.儿童肾移植术后微小病毒B19感染致难治性贫血2例[J/CD].中华临床医师杂志(电子版),2018,12(12):704-706.
|
[13] WURDINGER M,MODROW S,PLENTZ A. Impact of parvovirus B19 viremia in liver transplanted children on anemia:A retrospective study[J]. Viruses,2017,9(6):149.
|
[14] ZHANG JB,REN B,HUI R,et al. Clinical heterogeneity of human parvovirus B19 infection following adult liver transplantation[J]. Medicine(Baltimore),2018,97(34):e12074.
|
[15] CUI YF,LU W,GAO W,et al. Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HbcAb positive donor liver[J]. Chin Critical Care Med,2017,29(10):926-930.(in Chinese)崔羽丰,陆伟,高伟,等.主动免疫在预防HBcAb阳性供肝儿童肝移植术后新发乙型肝炎病毒感染中的应用[J].中华危重病急救医学,2017,29(10):926-930.
|
[16] JIMENEZ-PEREZ M,GONZALEZ-GRANDE R,MOSTAZO-TPRRES J,et al. Management of hepatitis B virus infection after liver transplantation[J]. World J Gastroenterol,2015,21(42):12083-12090.
|
[17] LIU RQ,ZHANG YC,YAO J,et al. Clinical efficacy of application of hepatitis B surface antigen-positive donor liver in liver transplantation[J]. Ogran Transplantation,2017,8(6):450-454.(in Chinese)刘荣强,张英才,姚嘉,等.乙型肝炎表面抗原阳性供肝肝移植的临床疗效分析[J].器官移植,2017,8(6):450-454.
|
[18] LIN CC,YONG CC,CHEN CL. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation[J].World J Gastroenterol,2015,21(39):11112-11117.
|
[19] TU ZY,SUN LY,ZHU ZJ,et al. Clinical study of de novo hepatitis B virus infection after pediatric living liver transplantation[J]. Ogran Transplantation,2015,6(4):245-248,267.(in Chinese)涂志越,孙丽莹,朱志军,等.儿童活体肝移植受者术后新发乙型肝炎病毒感染的临床研究[J].器官移植,2015,6(4):245-248,267.
|
[20] SU Y,HE EH,QIAN LX,et al. Application of ultrasound in the diagnosis of biliary complications after pediatric liver transplantation[J]. J Clin Exp Med,2016,15(22):2261-2265.(in Chinese)宿愿,何恩辉,钱林学,等.超声检查在儿童肝移植术后胆道并发症诊断中的应用价值[J].临床和实验医学杂志,2016,15(22):2261-2265.
|
[21] LUTHOLD SC,KASEJE N,JANNOT AS,et al. Risk factors for early and late biliary complications in pediatric liver transplantation[J]. Pediatr Transplant,2014,18(8):822-830.
|
[22] CAVALCANTE A,ZURSTRASSEN CE,CARNEVALE FC,et al.Long-term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation[J]. Am J Transplant,2018,18(9):2220-2228.
|
[23] LI XY,LI GM,HUANG L,et al. Clinical analysis of de novo neoplasms in patients after liver transplantation[J/CD]. Chin J Hepat Surg:Electronic Edition,2013,2(6):371-374.(in Chinese)李新宇,栗光明,黄磊,等.肝移植患者术后新发恶性肿瘤临床分析[J/CD].中华肝脏外科手术学电子杂志,2013,2(6):371-374.
|
[24] WANG X,CHEN H,FAN TY,et al. Clinical analysis on de novo malignancies after liver transplantation[J]. China Cancer,2017,26(5):410-414.(in Chinese)王旭,陈虹,范铁艳,等.肝移植术后新发恶性肿瘤的临床分析[J].中国肿瘤,2017,26(5):410-414.
|
[25] WANG Z,LI SP,ZHANG JJ. De novo digestive system malignancy after liver transplantation:A single-center clinical analysis of cases[J/CD]. Prac J Organ Transplant(Electronic Version),2016,4(1):37-39.(in Chinese)王振,李世朋,张建军.肝移植术后新发消化系统恶性肿瘤8例临床分析[J/CD].实用器官移植电子杂志,2016,4(1):37-39.
|
[26] ALLAIRE M,SEREE O,COILLU A,et al. De novo primary liver cancer after liver transplantation:A French national study on15803 patients[J]. Exp Clin Transplant,2018,16(6):779-780.
|
[27] DUFFY JP,KAO K,KO CY,et al. Long-term patient outcome and quality of life after liver transplantation:Analysis of20-year survivors[J]. Ann Surg,2010,252(4):652-661.
|
[28] NG VL,ALONSO EM,BUCUVALAS JC,et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada:Report of the studies of pediatric liver transplantation experience[J]. J Pediatr,2012,160(5):820-826,e823.
|
[29] KOSOLA S,LAMPELA H,LAURONEN J,et al. General health,health-related quality of life and sexual health after pediatric liver transplantation:A nationwide study[J]. Am J Transplant,2012,12(2):420-427.
|
[30] ANDERSEN MN,DORE-STITES D,GLEIT R,et al. A pilot study of the association between sleep disturbance in children with liver transplants and parent and family health-related quality of life[J]. J Pediatr Psychol,2014,39(7):735-742.
|
[31] HAAVISTO A,KORKMAN M,SINTONEN H,et al. Risk factors for impaired quality of life and psychosocial adjustment after pediatric heart,kidney,and liver transplantation[J]. Pediatr Transplant,2013,17(3):256-265.
|
[32] YAZIGI NA. Long term outcomes after pediatric liver transplantation[J]. Pediatr Gastroenterol Hepatol Nutr,2013,16(4):207-218.
|
[33] CHERVIN RD,HEDGER K,DILLON JE,et al. Pediatric sleep questionnaire(PSQ):Validity and reliability of scales for sleep-disordered breathing,snoring,sleepiness,and behavioral problems[J]. Sleep Med,2000,1(1):21-32.
|
[34] ARCHBOLD KH,PITUCH KJ,PANAHI P,et al. Symptoms of sleep disturbances among children at two general pediatric clinics[J]. J Pediatr,2002,140(1):97-102.
|
[35] CHERVIN RD,WEATHERLY RA,RUZICKA DL,et al. Subjective sleepiness and polysomnographic correlates in children scheduled for adenotonsillectomy vs other surgical care[J].Sleep,2006,29(4):495-503.
|
[36] YU Y,LU BS,WANG B,et al. Short sleep duration and adiposity in Chinese adolescents[J]. Sleep,2007,30(12):1688-1697.
|
[37] TAYLOR AL,WATSON CJ,BRADLEY JA. Immunosuppressive agents in solid organ transplantation:Mechanisms of action and therapeutic efficacy[J]. Crit Rev Oncol Hematol,2005,56(1):23-46.
|
[38] CHISHOLM MA,LANCE CE,WILLIAMSON GM,et al. Development and validation of an immunosuppressant therapy adherence barrier instrument[J]. Nephrol Dial Transplant,2005,20(1):181-188.
|
[39] ROTH T,ROEHRS T. Insomnia:Epidemiology,characteristics,and consequences[J]. Clin Cornerstone,2003,5(3):5-15.
|
[40] REILLY-SPONG M,PARK T,GROSS CR. Poor sleep in organ transplant recipients:Self-reports and actigraphy[J].Clin Transplantat,2013,27(6):901-913.
|
[41] HELDMAN MR,SOHN MW,GORDON EJ,et al. National survey of adult transplant hepatologists on the pediatric-to-adult care transition after liver transplantation[J]. Liver Transplant,2015,21(2):213-223.
|
[42] BELL LE,BARTOSH SM,DAVIS CL,et al. Adolescent transition to adult care in solid organ transplantation:A consensus conference report[J]. Am J Transplantat,2008,8(11):2230-2242.
|
[43] HARDEN PN,SHERSTON SN. Optimal management of young adult transplant recipients:The role of integrated multidisciplinary care and peer support[J]. Ann Saudi Med,2013,33(5):489-491.
|
[44] KREUZER M,PRUFE J,BETHE D,et al. The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care:study protocol for a randomized controlled trial[J]. Trials,2014,15:505.
|
[45] ZHANG M,LIU ZR,LI Y. Analysis of self-management status and influencing factors of postoperative liver transplantation patients[J]. Med Inf,2019,32(14):138-139.(in Chinese)张明,刘子荣,李妍.肝移植患者术后自我管理现状与影响因素分析[J].医学信息,2019,32(14):138-139.
|
[46] ZHAN XR,CHEN QE,TAN JL,et al. The self-care agency and its influencing factors in fiver transplant recipients a Rer discharge[J]. Chin J Nurs,2015,50(9):1091-1095.(in Chinese)占晓蕊,陈琪尔,谭坚铃,等.肝移植受者出院后自我护理能力及影响因素的调查[J].中华护理杂志,2015,50(9):1091-1095.
|
[47] LIANG L,LEI XM,ZHANG LP. Application of continuous nursing in improving self-care ability and quality of life of patients with liver transplantation[J]. Chin J Woman Child Health Res,2016,27(1):144.(in Chinese)梁琳,雷雪明,张丽萍.延续护理在提升肝移植患者自我护理能力和生活质量中的应用[J].中国妇幼健康研究,2016,27(1):144.
|
[48] MOAYED MS,EBADI A,KHODAVEISI M,et al. Factors influencing health self-management in adherence to care and treatment among the recipients of liver transplantation[J]. Patient Prefer Adherence,2018,12:2425-2436.
|
[49] ANNUNZIATO RA,BUCUVALAS JC,YIN W,et al. Selfmanagement measurement and prediction of clinical outcomes in pediatric transplant[J]. J Pediatr,2018,193:128-133.
|
[50] WEI L,LI J,CAO Y,et al. Quality of life and care burden in primary caregivers of liver transplantation recipients in China[J]. Medicine(Baltimore),2018,97(24):e10993.
|
[51] BUTT Z,DEW MA,LIU Q,et al. Psychological outcomes of living liver donors from a multi-center,prospective study:Results from the adult to adult living donor liver transplantation cohort study[J]. Am J Transplant,2017,17(5):1267-1277.
|
[52] ZHU XM. Demands and suggestions of medical social work intervention in children’s liver transplantation family[J]. Modern Hosp,2019,19(3):323-325.(in Chinese)朱修明.儿童肝移植家庭医务社会工作介入需求与建议[J].现代医院,2019,19(3):323-325.
|
[53] GOLD A,ROGERS A,CRUCHLEY E,et al. Assessment of school readiness in chronic cholestatic liver disease:A pilot study examining children with and without liver transplantation[J]. Can J Gastroenterol Hepatol,2017,2017:3125082.
|
[54] CALINESCU AM,MCLIN VA,BELLI D,et al. Psycho-social outcome in liver transplanted children:Beware of emotional self-assessment[J]. Ital J Pediatr,2012,38:37.
|